Pantoprazole Hikma (Pantoprazole)

Pantoprazole blocks the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. By inhibiting this final step of acid secretion, it raises gastric pH and maintains a less acidic environment, which promotes healing of acid‑related damage.

The prescribed dose of Pantoprazole Hikma is determined by the treating clinician based on the specific indication, patient age, renal and hepatic function, and treatment duration. Dosage recommendations are provided in the product’s prescribing information and should be followed exactly as directed by a healthcare professional.

Pantoprazole may be used during pregnancy or lactation only when the potential benefit justifies any potential risk to the fetus or infant. Clinicians should evaluate the individual situation and consider alternative therapies if appropriate. Limited data are available, so careful monitoring is advised.

To place an order, submit an enquiry on the Pantoprazole Hikma product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazole belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, it has a similar efficacy profile but may have a lower potential for drug‑drug interactions with certain antiplatelet agents.

Pantoprazole Hikma tablets should be stored at temperatures below 25 °C, in the original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the product’s potency and stability throughout its shelf life.

Pantoprazole Hikma is supplied as oral tablets that are taken with water, usually once daily in the morning before a meal. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated colitis, acute interstitial nephritis, hypomagnesemia and increased fracture risk with prolonged use. Patients should be advised to seek immediate medical attention if they experience symptoms such as rash, persistent diarrhea, swelling or muscle cramps.

Pantoprazole is contraindicated in individuals with known hypersensitivity to pantoprazole or any component of the formulation. Caution is also advised for patients with severe liver impairment, those taking certain antiretrovirals or antifungals that require an acidic environment, and patients with a history of osteoporosis when long‑term therapy is considered.